• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

住院 COVID-19 患者中肠道和口腔微生物群的改变及其与 SARS-CoV-2 病毒载量的关系。

Altered oral and gut microbiota and its association with SARS-CoV-2 viral load in COVID-19 patients during hospitalization.

机构信息

Center for Infection and Immunity, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong, China.

School of Public Health, Sun Yat-sen University, Guangzhou, Guangdong, China.

出版信息

NPJ Biofilms Microbiomes. 2021 Jul 22;7(1):61. doi: 10.1038/s41522-021-00232-5.

DOI:10.1038/s41522-021-00232-5
PMID:34294722
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8298611/
Abstract

The human oral and gut commensal microbes play vital roles in the development and maintenance of immune homeostasis, while its association with susceptibility and severity of SARS-CoV-2 infection is barely understood. In this study, we investigated the dynamics of the oral and intestinal flora before and after the clearance of SARS-CoV-2 in 53 COVID-19 patients, and then examined their microbiome alterations in comparison to 76 healthy individuals. A total of 140 throat swab samples and 81 fecal samples from these COVID-19 patients during hospitalization, and 44 throat swab samples and 32 fecal samples from sex and age-matched healthy individuals were collected and then subjected to 16S rRNA sequencing and viral load inspection. We found that SARS-CoV-2 infection was associated with alterations of the microbiome community in patients as indicated by both alpha and beta diversity indexes. Several bacterial taxa were identified related to SARS-CoV-2 infection, wherein elevated Granulicatella and Rothia mucilaginosa were found in both oral and gut microbiome. The SARS-CoV-2 viral load in those samples was also calculated to identify potential dynamics between COVID-19 and the microbiome. These findings provide a meaningful baseline for microbes in the digestive tract of COVID-19 patients and will shed light on new dimensions for disease pathophysiology, potential microbial biomarkers, and treatment strategies for COVID-19.

摘要

人类口腔和肠道共生微生物在免疫稳态的发展和维持中起着至关重要的作用,而它们与 SARS-CoV-2 感染的易感性和严重程度的关联尚未被充分了解。在这项研究中,我们调查了 53 名 COVID-19 患者在清除 SARS-CoV-2 前后口腔和肠道菌群的动态变化,然后将其微生物组的改变与 76 名健康个体进行了比较。共收集了这些 COVID-19 患者住院期间的 140 份咽喉拭子样本和 81 份粪便样本,以及 44 份咽喉拭子样本和 32 份年龄和性别匹配的健康个体的咽喉拭子样本和粪便样本,然后进行 16S rRNA 测序和病毒载量检测。我们发现,SARS-CoV-2 感染与患者微生物组群落的改变有关,这一点可以通过 alpha 和 beta 多样性指数来指示。鉴定出几种与 SARS-CoV-2 感染相关的细菌分类群,其中口腔和肠道微生物组中发现了升高的 Granulicatella 和 Rothia mucilaginosa。还计算了这些样本中的 SARS-CoV-2 病毒载量,以确定 COVID-19 与微生物组之间的潜在动态关系。这些发现为 COVID-19 患者消化道中的微生物提供了有意义的基线,将为疾病病理生理学、潜在的微生物生物标志物以及 COVID-19 的治疗策略提供新的视角。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a71/8298611/a1d356cb250d/41522_2021_232_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a71/8298611/8aa7af735d13/41522_2021_232_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a71/8298611/6b8a5a3ac6e8/41522_2021_232_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a71/8298611/7b46e4f8357e/41522_2021_232_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a71/8298611/a1d356cb250d/41522_2021_232_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a71/8298611/8aa7af735d13/41522_2021_232_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a71/8298611/6b8a5a3ac6e8/41522_2021_232_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a71/8298611/7b46e4f8357e/41522_2021_232_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a71/8298611/a1d356cb250d/41522_2021_232_Fig4_HTML.jpg

相似文献

1
Altered oral and gut microbiota and its association with SARS-CoV-2 viral load in COVID-19 patients during hospitalization.住院 COVID-19 患者中肠道和口腔微生物群的改变及其与 SARS-CoV-2 病毒载量的关系。
NPJ Biofilms Microbiomes. 2021 Jul 22;7(1):61. doi: 10.1038/s41522-021-00232-5.
2
Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.COVID-19 患者住院期间肠道微生物组的变化。
Gastroenterology. 2020 Sep;159(3):944-955.e8. doi: 10.1053/j.gastro.2020.05.048. Epub 2020 May 20.
3
The gut microbiome of COVID-19 recovered patients returns to uninfected status in a minority-dominated United States cohort.少数族群为主的美国队列中,COVID-19 康复患者的肠道微生物组恢复到未感染状态。
Gut Microbes. 2021 Jan-Dec;13(1):1-15. doi: 10.1080/19490976.2021.1926840.
4
SARS-CoV-2 infection and viral load are associated with the upper respiratory tract microbiome.SARS-CoV-2 感染和病毒载量与上呼吸道微生物组有关。
J Allergy Clin Immunol. 2021 Apr;147(4):1226-1233.e2. doi: 10.1016/j.jaci.2021.02.001. Epub 2021 Feb 9.
5
Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19.描绘 COVID-19 患者中 SARS-CoV-2 粪便病毒活性与肠道微生物群落组成的关系。
Gut. 2021 Feb;70(2):276-284. doi: 10.1136/gutjnl-2020-322294. Epub 2020 Jul 20.
6
Oral Microbiome Alterations and SARS-CoV-2 Saliva Viral Load in Patients with COVID-19.口腔微生物组改变与 COVID-19 患者唾液中 SARS-CoV-2 的病毒载量。
Microbiol Spectr. 2021 Oct 31;9(2):e0005521. doi: 10.1128/Spectrum.00055-21. Epub 2021 Oct 13.
7
Gut bacterial dysbiosis and instability is associated with the onset of complications and mortality in COVID-19.肠道细菌失调和不稳定与 COVID-19 并发症和死亡率的发生有关。
Gut Microbes. 2022 Jan-Dec;14(1):2031840. doi: 10.1080/19490976.2022.2031840.
8
Fecal shedding of SARS-CoV-2 in infants born to SARS-CoV-2 positive mothers: a pilot study.母亲感染 SARS-CoV-2 后所生婴儿粪便中 SARS-CoV-2 的排出:一项初步研究。
PeerJ. 2024 Aug 27;12:e17956. doi: 10.7717/peerj.17956. eCollection 2024.
9
Prolonged Impairment of Short-Chain Fatty Acid and L-Isoleucine Biosynthesis in Gut Microbiome in Patients With COVID-19.COVID-19 患者肠道微生物组中短链脂肪酸和 L-异亮氨酸生物合成的长期损伤。
Gastroenterology. 2022 Feb;162(2):548-561.e4. doi: 10.1053/j.gastro.2021.10.013. Epub 2021 Oct 21.
10
Signatures of COVID-19 Severity and Immune Response in the Respiratory Tract Microbiome.COVID-19 严重程度和呼吸道微生物组免疫反应特征。
mBio. 2021 Aug 31;12(4):e0177721. doi: 10.1128/mBio.01777-21. Epub 2021 Aug 17.

引用本文的文献

1
Comparative analysis of candidal carriage rates in long-term and short-term COVID-19 patients: An RT-PCR study.长期和短期新冠肺炎患者念珠菌携带率的比较分析:一项逆转录聚合酶链反应研究
J Oral Biol Craniofac Res. 2025 Jul-Aug;15(4):899-904. doi: 10.1016/j.jobcr.2025.06.014. Epub 2025 Jun 16.
2
Variations in oral health outcomes and mycobiome composition among COVID-19 convalescents.新冠康复者口腔健康结果与微生物组组成的差异。
Sci Rep. 2025 Jul 1;15(1):21638. doi: 10.1038/s41598-025-05078-x.
3
The Role of Beneficial Microbiota in COVID-19: Insights from Key Bacterial Genera.

本文引用的文献

1
Potential implications of SARS-CoV-2 oral infection in the host microbiota.严重急性呼吸综合征冠状病毒2型口腔感染对宿主微生物群的潜在影响。
J Oral Microbiol. 2020 Nov 29;13(1):1853451. doi: 10.1080/20002297.2020.1853451.
2
ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives.SARS-CoV-2 时代的血管紧张素转换酶 2:争议与新观点
Front Mol Biosci. 2020 Sep 30;7:588618. doi: 10.3389/fmolb.2020.588618. eCollection 2020.
3
What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2.
有益微生物群在2019冠状病毒病中的作用:关键细菌属的见解
Microorganisms. 2025 Apr 29;13(5):1029. doi: 10.3390/microorganisms13051029.
4
Altered microbiota of the lower respiratory tract and its association with COVID-19 severity analysed by metagenomics and metatranscriptomics.通过宏基因组学和宏转录组学分析下呼吸道微生物群的改变及其与COVID-19严重程度的关联。
Commun Biol. 2025 May 26;8(1):804. doi: 10.1038/s42003-025-08234-1.
5
Hospitalised children with COVID-19 display an aberrant intestinal microbiota and a shift in faecal compounds related with the metabolism of vitamins and lipids.新冠病毒感染住院儿童表现出肠道微生物群异常,以及与维生素和脂质代谢相关的粪便化合物变化。
PLoS One. 2025 May 20;20(5):e0323910. doi: 10.1371/journal.pone.0323910. eCollection 2025.
6
Gut Microbiome dysbiosis and immune activation correlate with somatic and neuropsychiatric symptoms in COVID-19 patients.肠道微生物群失调和免疫激活与新冠肺炎患者的躯体和神经精神症状相关。
J Transl Med. 2025 Mar 14;23(1):327. doi: 10.1186/s12967-025-06348-y.
7
Oral SARS-CoV-2 Infection and Risk for Long Covid.新型冠状病毒2型(SARS-CoV-2)的口腔感染与长期新冠的风险
Rev Med Virol. 2025 Mar;35(2):e70029. doi: 10.1002/rmv.70029.
8
The relationship between gut and nasopharyngeal microbiome composition can predict the severity of COVID-19.肠道微生物群与鼻咽微生物群组成之间的关系可以预测新冠肺炎的严重程度。
Elife. 2025 Feb 18;13:RP95292. doi: 10.7554/eLife.95292.
9
A Pilot Study of the Gut Microbiota in Spine Fusion Surgery Patients.脊柱融合手术患者肠道微生物群的初步研究。
HSS J. 2025 Feb;21(1):65-72. doi: 10.1177/15563316231201410. Epub 2023 Sep 26.
10
Assessment of upper respiratory and gut bacterial microbiomes during COVID-19 infection in adults: potential aerodigestive transmission.成人新冠病毒感染期间上呼吸道和肠道细菌微生物群评估:气消化道传播的可能性
Sci Rep. 2025 Jan 13;15(1):1811. doi: 10.1038/s41598-025-85806-5.
什么是有效的 COVID-19 疫苗?评估针对 SARS-CoV-2 的疫苗临床疗效的挑战综述。
Lancet Infect Dis. 2021 Feb;21(2):e26-e35. doi: 10.1016/S1473-3099(20)30773-8. Epub 2020 Oct 27.
4
Oral Microbiome and SARS-CoV-2: Beware of Lung Co-infection.口腔微生物群与新型冠状病毒:谨防肺部合并感染。
Front Microbiol. 2020 Jul 31;11:1840. doi: 10.3389/fmicb.2020.01840. eCollection 2020.
5
The role of oral bacteria in COVID-19.口腔细菌在2019冠状病毒病中的作用。
Lancet Microbe. 2020 Jul;1(3):e105. doi: 10.1016/S2666-5247(20)30057-4. Epub 2020 Jul 3.
6
Potential diagnostics and therapeutic approaches in COVID-19.COVID-19 的潜在诊断和治疗方法。
Clin Chim Acta. 2020 Nov;510:488-497. doi: 10.1016/j.cca.2020.08.013. Epub 2020 Aug 12.
7
The Intermucosal Connection between the Mouth and Gut in Commensal Pathobiont-Driven Colitis.口腔与肠道共生菌驱动的结肠炎中的黏膜连接。
Cell. 2020 Jul 23;182(2):447-462.e14. doi: 10.1016/j.cell.2020.05.048. Epub 2020 Jun 16.
8
Viable SARS-CoV-2 in various specimens from COVID-19 patients.不同 COVID-19 患者样本中存活的 SARS-CoV-2。
Clin Microbiol Infect. 2020 Nov;26(11):1520-1524. doi: 10.1016/j.cmi.2020.07.020. Epub 2020 Jul 23.
9
Oral Probiotic Bifidobacterium Longum Supplementation Improves Metabolic Parameters and Alters the Expression of the Renin-Angiotensin System in Obese Mice Liver.口服益生菌长双歧杆菌补充剂可改善肥胖小鼠肝脏的代谢参数并改变肾素-血管紧张素系统的表达。
Biol Res Nurs. 2021 Jan;23(1):100-108. doi: 10.1177/1099800420942942. Epub 2020 Jul 23.
10
Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19.血管紧张素转化酶 2(ACE2)在 COVID-19 中的作用。
Crit Care. 2020 Jul 13;24(1):422. doi: 10.1186/s13054-020-03120-0.